Zeto Secures $31 Million to Advance AI-Driven EEG Diagnostics

Summary: Zeto Inc, a medical technology company focused on EEG diagnostics, announced the completion of a $31 million funding round led by MindWorks Global. The investment will support Zeto’s efforts to expand its commercial and operational teams, enhance research and development, and drive growth in its AI-powered cloud platform. The company’s solutions have been adopted…

Read More

NLS Pharmaceutics Completes Initial $500K Financing to Advance Kadimastem Merger

Summary: NLS Pharmaceutics Ltd, a biotechnology company developing a dual orexin agonist platform, announced the completion of the initial $500,000 closing of a $1 million financing agreement with an accredited investor. The agreement, executed at $3.10 per share—48% above the market closing price prior to the company’s extraordinary general meeting—does not include warrants. This financing,…

Read More

Smart Earbuds Use EEG Technology to Improve Sleep

Summary: At CES 2025, NextSense debuted its new consumer brand, Tone, and introduced Tone Buds, brain-sensing earbuds designed to improve sleep quality and optimize brain health. Equipped with clinical-grade EEG technology, Tone Buds monitor brain activity during sleep and provide real-time enhancements, including pink noise stimulation during deep sleep to promote restoration. The earbuds aim…

Read More

SICAT Simplifies Oral Appliance Ordering and Enhances 3D Imaging Capabilities

Summary: SICAT has introduced a new workflow for its Optisleep oral appliance, allowing dentists to order the device without the need for CBCT scans by using optical impressions. The company has also announced a partnership with Vatech, integrating its SICAT Suite of applications with Vatech’s 3D imaging software to support diagnostics and treatment planning for…

Read More

AI-Powered Video Analysis Accurately Detects REM Sleep Behavior Disorder 

Summary: Researchers have developed an AI-powered algorithm that analyzes 2D video recordings from routine sleep studies to improve the diagnosis of REM sleep behavior disorder. The disorder, often an early indicator of Parkinson’s disease or dementia, causes abnormal movements during REM sleep and is challenging to diagnose due to subtle and variable symptoms. The AI…

Read More

Is Your Job Ruining Your Sleep? New Study Says It Might Be

Summary: A study led by the University of South Florida found that sedentary jobs and nontraditional work schedules significantly increase the risk of poor sleep health, including insomnia symptoms and the need for frequent “catch-up sleep.” The research, spanning over a decade and involving more than 1,000 workers, highlights how workplace design influences long-term sleep…

Read More

Trial to Explore Investigational Drug’s Dual Impact on Sleep Apnea and Hypertension

Summary: Mineralys Therapeutics has received FDA clearance for a phase 2 clinical trial of lorundrostat, a drug designed to address moderate-to-severe obstructive sleep apnea (OSA) and hypertension. The trial aims to assess lorundrostat’s ability to reduce upper airway obstruction and nocturnal hypertension, conditions linked to poor cardiovascular outcomes. The placebo-controlled study will enroll approximately 40…

Read More